SCHEMBL6359265

SCHEMBL6359265

O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc(S(=O)(=O)n2ccc3ccccc32)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.57
HTT P42858 2/20 0.57
KMT2A Q03164 2/20 0.57
PKM P14618 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
PPARG P37231 11/20 0.55
PPARD Q03181 11/20 0.55
PPARA Q07869 11/20 0.55
AKR1C4 P17516 1/20 0.52
AKR1C3 P42330 1/20 0.52
AKR1C2 P52895 1/20 0.52
AKR1C1 Q04828 1/20 0.52
FABP4 P15090 1/20 0.51
HDAC1 Q13547 2/20 0.51
ALB P02768 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
MAPT P10636 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6350593 0.90 PPARG (0.69) PPARGPPARDPPARAAKR1C4AKR1C3
SCHEMBL6351914 0.87 PPARG (0.65) PPARGPPARDPPARA
SCHEMBL6350433 0.87 PPARG (0.55) PPARGPPARDPPARAAKR1C4AKR1C3
SCHEMBL6352169 0.87 PPARG (0.55) KMT2APPARGPPARDPPARAAKR1C4
SCHEMBL6349494 0.87 PPARG (0.65) PPARGPPARDPPARAFABP4HDAC1
SCHEMBL6350313 0.85 HDAC1 (0.68) L3MBTL1PPARGPPARDPPARAFABP4
SCHEMBL6360128 0.85 CYP2C19 (0.52) PKML3MBTL1PPARGPPARDPPARA
SCHEMBL6357902 0.83 PPARG (0.49) PPARGPPARDPPARAAKR1C4AKR1C3
SCHEMBL6358668 0.82 PPARG (0.49) HTTL3MBTL1PPARGPPARDPPARA
SCHEMBL6350776 0.82 AKR1C2 (0.56) MEN1KMT2APPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 MEN1 3274/4885HTT 2677/4885KMT2A 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.